Episode 110: FDA Takes on Tobacco Use and Its Impact on Cancer Care

Jul 3, 2020

Mitch Zeller, JD, director of the U.S. Food and Drug Administration’s (FDA’s) Center for Tobacco Products, joins Lisa Kennedy Sheldon, PhD, APRN, AOCNP^®, FAAN, ONS’s clinical and scientific affairs liaison, to discuss tobacco’s effect on American health, communication strategies for patients with cancer who want to quit, and what FDA is doing to mitigate its harm. 

Music Credit: "Fireflies and Stardust" by Kevin MacLeod 

Licensed under Creative Commons by Attribution 3.0 

Episode Notes 

Check out these resources from today’s episode: 

• The NCPD activity for this episode has expired, but you can still earn NCPD through many other Oncology Nursing Podcast episodes. Find a full list of opportunities.
• ONS E-Cigarettes and Vaping Position Statement 

• ONS-endorsed ISNCC Tobacco Position Statement 

• ONS Vaping Learning Library 

• Oncology Nursing Podcast Episode 55: The Youth Vaping Epidemic 

• Oncology Nursing Forum article: Smoking Prevalence and Management Among Cancer Survivors 

• ONS Voice article: Vaping, E-Cigarettes, and Flavored Tobacco Are Reversing 20 Years of Decreasing Smoking Rates 

• Mitch Zeller’s biography 

• FDA Center for Tobacco Products 

• FDA Center for Tobacco Products’ Youth Tobacco Prevention Plan 

• The first U.S. surgeon general’s report on smoking (1964) 

• 2014 Surgeon General's Report: The Health Consequences of Smoking—50 Years of Progress 

• National Academies of Sciences’ Public Health Consequences of E-Cigarettes 2018 report 

• FDA’s Real Cost campaign 

• FDA’s Every Try Counts campaign